Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06729164 · ClinicalTrials.gov registry record · NA
Strategic and Interactive Signing Instruction Experiment
A NA study of Sign Language Skills and Teacher Practice, sponsored by The University of Tennessee, Knoxville.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06729164: Active NA study of Sign Language Skills and Teacher Practice, sponsored by The University of Tennessee, Knoxville.
NCT06729164 is a NA study of Sign Language Skills and Teacher Practice that is active but no longer recruiting, run by The University of Tennessee, Knoxville. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06729164, a NA study of Sign Language Skills and Teacher Practice, is active but no longer recruiting, sponsored by The University of Tennessee, Knoxville.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This RCT study involves teachers divided into an experimental group and a control group. Teachers in the experimental group will receive SISI training to support the sign language development of deaf children, while those in the control group will continue with "business-as-usual" teaching methods. Pre- and post-assessments will be conducted for all deaf children at the beginning and end of the school year.
Primary Outcome
Student data will be analyzed using rubrics adapted from the National Assessment of Educational Progress (NAEP) standardized writing assessments.
Conditions Studied
Interventions
- BEHAVIORAL Strategic and Interactive Signing Instruction
- BEHAVIORAL Business-As-Usual Instruction
Study Locations (1)
Tennessee
- University of Tennessee, Knoxville - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What the registry record for NCT06729164 still lists
NCT06729164 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Sign Language Skills appearing as the primary indexed condition, and to 2 interventions - of which Strategic and Interactive Signing Instruction is the first listed.
NCT06729164 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06729164 about?
NCT06729164 is a clinical study titled "Strategic and Interactive Signing Instruction Experiment". This RCT study involves teachers divided into an experimental group and a control group. Teachers in the experimental group will receive SISI training to support the sign language development of deaf children, while those in the control group will continue with "business-as-usual" teaching methods. ...
What is the current status of trial NCT06729164?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-04-01. Estimated completion is 2026-07-30.
What conditions does trial NCT06729164 study?
This clinical trial studies the following conditions: Sign Language Skills, Teacher Practice.
What interventions are being tested in trial NCT06729164?
The interventions under investigation include: Strategic and Interactive Signing Instruction (BEHAVIORAL), Business-As-Usual Instruction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06729164?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06729164 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sign Language Skills
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06729164's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI